Famotidine (oral)

Revision as of 18:53, 9 January 2015 by Kiran Singh (talk | contribs)
Jump to navigation Jump to search

Famotidine (oral)
Adult Indications & Dosage
Pediatric Indications & Dosage
Contraindications
Warnings & Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Administration & Monitoring
Overdosage
Pharmacology
Clinical Studies
How Supplied
Images
Patient Counseling Information
Precautions with Alcohol
Brand Names
Look-Alike Names

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Kiran Singh, M.D. [2]

Disclaimer

WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.

Overview

Famotidine (oral) is a {{{drugClass}}} that is FDA approved for the treatment of heartburn. Common adverse reactions include constipation ,diarrhea, dizziness , headache.

Adult Indications and Dosage

FDA-Labeled Indications and Dosage (Adult)

Indications

  • Duodenal ulcer
  • Esophagitis - Gastroesophageal reflux disease,
  • Gastric hypersecretion
  • Gastric ulcer,
  • Gastroesophageal reflux disease
  • Indigestion

Off-Label Use and Dosage (Adult)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Famotidine (oral) in adult patients.

Non–Guideline-Supported Use

Indications

  • Esophagitis, Maintenance
  • Gastritis
  • Gastrointestinal hemorrhage
  • Stress ulcer
  • Urticaria

Pediatric Indications and Dosage

FDA-Labeled Indications and Dosage (Pediatric)

Indication

  • Duodenal ulcer
  • Esophagitis - Gastroesophageal reflux disease,
  • Gastric hypersecretion
  • Gastric ulcer,
  • Gastroesophageal reflux disease
  • Indigestion

Off-Label Use and Dosage (Pediatric)

Non–Guideline-Supported Use

Indications

  • Stress ulcer; Prophylaxis

Contraindications

There is limited information regarding Famotidine (oral) Contraindications in the drug label.

Warnings

There is limited information regarding Famotidine (oral) Warnings' in the drug label.

Adverse Reactions

Clinical Trials Experience

There is limited information regarding Famotidine (oral) Clinical Trials Experience in the drug label.

Postmarketing Experience

There is limited information regarding Postmarketing Experience of Famotidine (oral) in the drug label.

Body as a Whole
Cardiovascular
Digestive
Endocrine
Hematologic and Lymphatic
Metabolic and Nutritional
Musculoskeletal
Neurologic
Respiratory
Skin and Hypersensitivy Reactions
Special Senses
Urogenital
Miscellaneous

Drug Interactions

  • Drug
  • Description

Use in Specific Populations

Pregnancy

Pregnancy Category (FDA):

  • Pregnancy Category


Pregnancy Category (AUS):

  • Australian Drug Evaluation Committee (ADEC) Pregnancy Category

There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Famotidine (oral) in women who are pregnant.

Labor and Delivery

There is no FDA guidance on use of Famotidine (oral) during labor and delivery.

Nursing Mothers

There is no FDA guidance on the use of Famotidine (oral) with respect to nursing mothers.

Pediatric Use

There is no FDA guidance on the use of Famotidine (oral) with respect to pediatric patients.

Geriatic Use

There is no FDA guidance on the use of Famotidine (oral) with respect to geriatric patients.

Gender

There is no FDA guidance on the use of Famotidine (oral) with respect to specific gender populations.

Race

There is no FDA guidance on the use of Famotidine (oral) with respect to specific racial populations.

Renal Impairment

There is no FDA guidance on the use of Famotidine (oral) in patients with renal impairment.

Hepatic Impairment

There is no FDA guidance on the use of Famotidine (oral) in patients with hepatic impairment.

Females of Reproductive Potential and Males

There is no FDA guidance on the use of Famotidine (oral) in women of reproductive potentials and males.

Immunocompromised Patients

There is no FDA guidance one the use of Famotidine (oral) in patients who are immunocompromised.

Administration and Monitoring

Administration

  • Oral
  • Intravenous

Monitoring

There is limited information regarding Monitoring of Famotidine (oral) in the drug label.

  • Description

IV Compatibility

There is limited information regarding IV Compatibility of Famotidine (oral) in the drug label.

Overdosage

Acute Overdose

Signs and Symptoms

  • Description

Management

  • Description

Chronic Overdose

There is limited information regarding Chronic Overdose of Famotidine (oral) in the drug label.

Pharmacology

There is limited information regarding Famotidine (oral) Pharmacology in the drug label.

Mechanism of Action

Structure

File:Famotidine (oral)01.png
This image is provided by the National Library of Medicine.

Pharmacodynamics

There is limited information regarding Pharmacodynamics of Famotidine (oral) in the drug label.

Pharmacokinetics

There is limited information regarding Pharmacokinetics of Famotidine (oral) in the drug label.

Nonclinical Toxicology

There is limited information regarding Nonclinical Toxicology of Famotidine (oral) in the drug label.

Clinical Studies

There is limited information regarding Clinical Studies of Famotidine (oral) in the drug label.

How Supplied

Storage

There is limited information regarding Famotidine (oral) Storage in the drug label.

Images

Drug Images

{{#ask: Page Name::Famotidine (oral) |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}

Package and Label Display Panel

{{#ask: Label Page::Famotidine (oral) |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}

Patient Counseling Information

There is limited information regarding Patient Counseling Information of Famotidine (oral) in the drug label.

Precautions with Alcohol

  • Alcohol-Famotidine (oral) interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.

Brand Names

Look-Alike Drug Names

Drug Shortage Status

Price

References

The contents of this FDA label are provided by the National Library of Medicine.

  1. ↑ Empty citation (help)
  2. ↑ "http://www.ismp.org". External link in |title= (help)

{{#subobject: 

 |Page Name=Famotidine (oral)
 |Pill Name=No image.jpg
 |Drug Name=
 |Pill Ingred=|+sep=;
 |Pill Imprint=
 |Pill Dosage={{{dosageValue}}} {{{dosageUnit}}}
 |Pill Color=|+sep=;
 |Pill Shape=
 |Pill Size (mm)=
 |Pill Scoring=
 |Pill Image=
 |Drug Author=
 |NDC=

}}

{{#subobject: 

 |Label Page=Famotidine (oral)
 |Label Name=Famotidine (oral)11.png

}}

{{#subobject: 

 |Label Page=Famotidine (oral)
 |Label Name=Famotidine (oral)11.png

}}

Retrieved from "https://www.wikidoc.org/index.php?title=Famotidine_(oral)&oldid=1053209"